hi INDiA
South Asian Views On Global News - Update 24X7

India to consider clinical trials data of two full doses of AstraZeneca vaccine

BUY-SELL | HELP WANTED | MATRIMONIAL

India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which is claimed to be up to 90% effective but has attracted criticism for dosing errors.India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which is claimed to be up to 90% effective but has attracted criticism for dosing errors.

gtag('set', {'user_id': 'USER_ID'}); // Set the user ID using signed-in user_id.